Propanc Biopharma Inc.
PPCB | NASDAQ
$1.84
-$0.27 (-12.80%)
At close: Oct 30, 2026, 4:00 PM ET
$1.98
+$0.14 (+7.61%)
Pre-market:
Nov 2, 2026, 6:14 AM ET
Market Data
Market Cap $1.9M
Enterprise Value $1.58M
Beta 3.33
Average Volume 203.38K
Shares Outstanding (Diluted) 112.37K
Shares Change YoY 607.94%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US74346N8838
Price Performance
Price Change 1M -63.7%
Price Change 3M -82.5%
Price Change 6M -92.9%
Price Change YTD -98.6%
Price Change 1Y -99.3%
Price Change 3Y -100.0%
Price Change 5Y -100.0%
1M CAGR (ann.) -69.8%
1Y CAGR (ann.) -99.4%
5Y CAGR (ann.) -98.0%
All-Time CAGR -97.5%
Valuation
PE Ratio -0.01
Forward PE N/A
PEG Ratio -0.00
Forward PEG -0.00
PS Ratio N/A
Forward PS N/A
PB Ratio 0.20
P/FCF Ratio -0.33
P/Adj. FCF Ratio -0.33
P/OCF Ratio -0.04
EV/Sales N/A
EV/EBIT -0.09
EV/EBITDA -0.09
EV/FCF -0.28
Earnings Yield -17044.0%
FCF Yield -299.2%
Adj. FCF Yield -299.2%
Financial Health
Net Cash $346.71K
Total Debt $509.12K
Cash & Short-Term Investments $832.01K
Total Assets $12.78M
Current Ratio 2.55
Quick Ratio 2.55
Debt / Equity Ratio 0.05
Debt / EBITDA -0.03
Debt / FCF -0.09
OCF / Debt -11.17
Interest Coverage -42.24
Altman Z-Score -19.76
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -147.6%
Return on Equity -167.5%
Return on Invested Capital -183.5%
Return on Capital Employed -192.9%
Return on Tangible Assets -147.6%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 148.3%
EPS CAGR 5Y 95.0%
EPS CAGR 10Y 47.5%
FCF CAGR 3Y -101.4%
FCF CAGR 5Y -41.2%
FCF CAGR 10Y -5.0%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Oct 5, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-5.69M
Free Cash Flow $-5.69M
Adj. Free Cash Flow $-5.69M
FCF Per Share -$50.62
OCF Per Share -$50.62
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-18.19M
EBITDA $-18.41M
Net Income $-18.86M
EPS (Diluted) -$313.61
Revenue / Employee N/A
Profit / Employee $-9.43M
Employees 2
Add to Watchlist
Select watchlists to add or remove PPCB